Effect of mitochondrial oxidative stress on regulatory T cell manufacturing for clinical application in transplantation: Results from a pilot study
American Journal of Transplantation · 2025
DOI: 10.1016/j.ajt.2024.10.024 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Transplantation, 2025. Verfasst von Roberto Gedaly und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery - Transplant Division, College of Medicine, University of Kentucky, Lexington, Kentucky, USA; Lucille Parker Markey Cancer Cent…. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Oxidative Stress, Mitochondria, Kidney Transplantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIBIB NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
The manufacturing process of regulatory T (Treg) cells for clinical application begins with the positive selection of CD25+ cells using superparamagnetic iron oxide nanoparticle (SPION)-conjugated anti-CD25 antibodies (spCD25) and immunomagnetic cell separation technology. Our findings revealed that the interaction of spCD25 with its cell target induced the internalization of the complex spCD25-interleukin-2 receptor. Accumulation of intracellular spCD25 triggered oxidative stress, causing delayed Treg expansion and temporary reduction in suppressor activity. This activation delay hindered the efficient generation of clinically competent cells. During this early phase, Treg cells exhibited elevated mitochondrial superoxide and lipid peroxidation levels, with a concomitant decrease in mitochondrial respiration rates. The results uncovered the increased mitochondrial unfolded protein response. This protective, redox-sensitive activity is inherent in Tregs when contrasted with homologous, spCD25-treated, conventional T cells. Although the temporary effects of spCD25 on clinically competent cells did not impede their use in a safety/feasibility pilot study with kidney transplant recipients, it is reasonable to anticipate a potential reduction in their therapeutic efficacy. The mechanistic understanding of the adverse effects triggered by spCD25 is crucial for improving the manufacturing process of clinically competent Treg cells, a pivotal step in the successful implementation of immune cell therapy in transplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery - Transplant Division, College of Medicine, University of Kentucky, Lexington, Kentucky, USA; Lucille Parker Markey Cancer Center, University of Kentucky, College of Medicine, Lexington, Kentucky,…
- Department of Surgery - Transplant Division, College of Medicine, University of Kentucky, Lexington, Kentucky, USA. Electronic address: orozcog@ohsu.edu.
- Department of Surgery - Transplant Division, College of Medicine, University of Kentucky, Lexington, Kentucky, USA. Electronic address: lillie.lewis@uky.edu.
- Department of Surgery - Transplant Division, College of Medicine, University of Kentucky, Lexington, Kentucky, USA. Electronic address: deepa.valvi@uky.edu.
- Lucille Parker Markey Cancer Center, University of Kentucky, College of Medicine, Lexington, Kentucky, USA; Alliance Research Initiative (TILT Alliance), University of Kentucky College of Medicine, Lexington, Kentucky,…
- Pathology and Laboratory Medicine, University of Kentucky, College of Medicine, Lexington, Kentucky, USA. Electronic address: giovanna.hidalgo@uky.edu.
Förderung
- NCI NIH HHS
- NIBIB NIH HHS
- NCATS NIH HHS
- National Cancer Institute
- National Institute of Biomedical Imaging and Bioengineering
- National Center for Advancing Translational Sciences
- National Institutes of Health
- Office of the Vice President for Research and Partnerships
Zitieren
APA
Gedaly, R., Orozco, G., Lewis, L. J., Valvi, D., Chapelin, F., Khurana, A., Hidalgo, G. E., Shmookler, A., Tripathi, A., Zhang, C., Zwischenberger, J. B., & Marti, F. (2025). Effect of mitochondrial oxidative stress on regulatory T cell manufacturing for clinical application in transplantation: Results from a pilot study. American Journal of Transplantation. https://doi.org/10.1016/j.ajt.2024.10.024
Vancouver
Gedaly R, Orozco G, Lewis LJ, Valvi D, Chapelin F, Khurana A, et al. Effect of mitochondrial oxidative stress on regulatory T cell manufacturing for clinical application in transplantation: Results from a pilot study. American Journal of Transplantation. 2025. doi:10.1016/j.ajt.2024.10.024
BibTeX
@article{Gedaly2025,
author = {Gedaly, Roberto and Orozco, Gabriel and Lewis, Lillie J and Valvi, Deepa and Chapelin, Fanny and Khurana, Aman and Hidalgo, Giovanna E and Shmookler, Aaron and Tripathi, Aashutosh and Zhang, Cuiping and Zwischenberger, Joseph B and Marti, Francesc},
title = {Effect of mitochondrial oxidative stress on regulatory T cell manufacturing for clinical application in transplantation: Results from a pilot study},
journal = {American Journal of Transplantation},
year = {2025},
doi = {10.1016/j.ajt.2024.10.024}
}
EUVIMED